Article
CRISPR-mediated deletion of the Protein tyrosine phosphatase, non-receptor type 22…
medRxiv · 2020 · Prade, S.; Wright, D.; Logan, N.; Teagle, A. R.; Stauss, H. J.; Zamoyska, R.
Key facts
| Title | CRISPR-mediated deletion of the Protein tyrosine phosphatase, non-receptor type 22 (PTPN22) improves human T cell function for adoptive T cell therapy |
|---|---|
| First author | Prade, S.; Wright, D.; Logan, N.; Teagle, A. R.; Stauss, H. J.; Zamoyska, R. |
| Journal | medRxiv |
| Published | Dec 4, 2020 |
| DOI | 10.1101/2020.12.03.410043 |
| Devices mentioned | K153538 |
| Product codes mentioned | GKZ, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1